Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2025-12-24 @ 3:24 PM
NCT ID:
NCT06229392
Eligibility Criteria:
Inclusion Criteria:
* ECOG 0-2
* Patients must be planning to receive standard of car e neoadjuvant chemotherapy as defined by the most recent version of NCCN guidelines (www.nccn.org)
* Patients must have histologically or cytologically confirmed invasive breast cancer that is either triple-negative or HER2+ (regardless of hormone receptor status)
Exclusion Criteria:
* Patients with any uncontrolled intercurrent illness.
* Patients who have any underlying medical condition for which, in the investigator's opinion, participation would not be in the best interest of the participant
* History of egg allergy
* Patients currently on anticoagulant therapy, corticosteroids, or immunosuppressive agents
* History of allergic reactions attributed to compounds of similar chemical or biologic composition to the seasonal flu vaccine.
* History of Guillain-Barré syndrome
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06229392
Study Brief:
Protocol Section:
NCT06229392